Molecular modelling of mammalian CYP2B isoforms and their interaction with substrates, inhibitors and redox partners

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
D F Lewis, B G Lake

Abstract

1. The construction of three-dimensional models of CYP2B isozymes from rat (CYP2B1), rabbit (CYP2B4) and man (CYP2B6), based on a multiple sequence alignment with CYP102, a unique eukaryotic-like bacterial P450 (in terms of possessing an NADPH-dependent FAD- and FMN-containing oxidoreductase redox partner) of known crystal structure, is reported. 2. The enzyme models described are shown to be consistent with experimental evidence from site-directed mutagenesis studies, antibody recognition sites and amino acid residues identified as being associated with redox partner interactions, together with the location of a key serine residue (Ser-128) likely to be involved in protein kinaseA-mediated phosphorylation. 3. A substantial number of known substrates and inhibitors of CYP2B isozymes are shown to fit the putative active sites of the enzyme models in agreement with their reported position of metabolism or mode of inhibition respectively. In particular, there is complementarity between the characteristic non-planar geometries of CYP2B substrates and key groups in the enzymes' active sites. 4. Molecular modelling of CYP2B isozymes appears to rationalize a number of the reported findings from quantitative structure-activity relation...Continue Reading

References

Feb 1, 1992·The Biochemical Journal·D J Waxman, L Azaroff
Jan 6, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P R Ortiz de MontellanoJ A Peterson
Jan 1, 1992·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P Soucek, I Gut
Feb 1, 1990·The Journal of Pharmacy and Pharmacology·M M HasanA A Abdelaziz
Apr 30, 1985·Biochemical and Biophysical Research Communications·K Inouye, M J Coon
Mar 15, 1981·Biochemical Pharmacology·M W KennedyL S Kaminsky
Jan 1, 1981·Pharmacology & Therapeutics·J B SchenkmanD L Cinti
Jan 1, 1981·Drug Metabolism Reviews·B Testa, P Jenner
Jun 1, 1994·European Journal of Biochemistry· Uvarov VYuA I Archakov
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·J R Halpert
May 15, 1995·International Journal of Radiation Oncology, Biology, Physics·K WallnerL Harrison
Dec 1, 1994·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·V Nedelcheva, I Gut
Jan 1, 1994·Drug Metabolism Reviews·F J Gonzalez, H V Gelboin
Apr 1, 1994·Toxicology and Applied Pharmacology·J R HalpertM A Correia
May 1, 1994·Toxicology and Applied Pharmacology·T S PoetJ R Halpert
Nov 1, 1993·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D J BerryD V Parke
Oct 11, 1993·FEBS Letters·K N Degtyarenko, A I Archakov
Jan 1, 1995·Drug Metabolism Reviews·M Spatzenegger, W Jaeger
Jan 1, 1996·Reviews of Physiology, Biochemistry and Pharmacology·R Bernhardt
Aug 1, 1994·Journal of Biomolecular Structure & Dynamics·Grazyna D SzklarzJames R Halpert

❮ Previous
Next ❯

Citations

May 15, 2012·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·M Denise Dearing
May 2, 2002·Biochimica Et Biophysica Acta·Gaston Hui Bon HoaStephen G Sligar
Mar 30, 2002·Advanced Drug Delivery Reviews·Stewart B KirtonMichael J Sutcliffe
Sep 18, 2001·European Journal of Biochemistry·P Hlavica, D F Lewis
Oct 5, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Dan YaoChi Chen
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R E White
Nov 26, 2009·Journal of Environmental and Public Health·N E UdonwaB O Okon
May 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Timothy H Bayburt, Stephen G Sligar
Aug 26, 1999·Drug Metabolism Reviews·S Ekins, S A Wrighton
Mar 30, 2010·Ecotoxicology and Environmental Safety·Jeferson Luis FrancoAlcir Luiz Dafre
Dec 16, 1998·Chemico-biological Interactions·D F LewisP S Goldfarb
Dec 8, 2004·Archives of Biochemistry and Biophysics·Carol A KempMichael J Sutcliffe
Sep 12, 2006·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·M D DearingM J Bastiani
May 2, 2003·The Journal of Pharmacology and Experimental Therapeutics·Hsia-Lien LinPaul F Hollenberg
Jan 17, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shigeyuki KitamuraShigeru Ohta

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.